«‹123»Seite
3 Artikel mit Literatur, Seite 1 von 3

POLITIK: Medizinreport

Multivitaminpräparate: Große Hoffnungen – keine Beweise

Dtsch Arztebl 2000; 97(37): A-2360 / B-2016 / C-1892

Meyer, Frank P.

 1. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–1035.
 2. Anderson TW, Reid DBW, Beaton GH: Vitamin C and the common cold: a double-blind trial. Can Med Assoc J 1972; 107: 503–508.
 3. Barnes FE: Vitamin supplements and the incidence of colds in high school basketball players. N C Med. J. 1961; 22–26.
 4. Coulehan JL, Reisinger KS, Rogers KD, Bradley DW: Vitamin C prophylaxis in a boarding school. N Engl J Med 1974; 290: 6–10.
 5. Duffy SJ, Gokce N, Holbrook M et al.: Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048–2049.
 6. Gale CR, Martyn CN, Winter PD, Cooper C: Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J 1995; 310: 1563–1566.
 7. Gey KF, Stähelin HB, Eichholzer M: Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Investig 1993; 71: 3–6.
 8. GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447–455.
 9. Greenberg ER, Baron JA, Tosteson TD et al. for the Polyp Prevention Study Group: A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331: 141–147.
10. The Heart Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154–160.
11. Hennekens CH, Buring JE, Manson JAE et al.: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145–1149.
12. Kardinaal AF, Kok FJ, Kohlmeier L et al.: Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. Am J Epidemiol 1997; 145: 373–379.
13. Khatta M, Alexander BS, Krichten CM et al.: The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med 2000; 132: 636–640.
14. Lengfelder W: Antioxidative Vitamine: Prävention von kardiovaskulären Erkrankungen. Dtsch med Wschr 1998; 123: 1014–1017.
15. Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y: Criteria and recommendations for vitamin C intake. JAMA 1999; 281: 1415–1423.
16. Liu S, Ajani U, Chae C et al.: Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 1999; 282: 1073–1075.
17. Melhus H, Michaëlsson K, Kindmark A et al.: Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998;129: 770–778.
18. Meyer FP: Statine in der Sekundär- und Primärprävention der koronaren Herzerkrankung? Reduktion der Risiken – Reduktion der Ereignisse – Number needed to treat. Internist Prax 1999; 39: 849–858.
19. Meyer FP: Schlußwort zu Statine in der Sekundär- und Primärprävention der koronaren Herzerkrankung? Internist Prax 2000; 40: 152–154.
20. Meyer FP: Hochdruckbehandlung – weniger kann mehr sein. Internist Prax 2000; 40: 467–484.
21. Omenn GS, Goodman GE, Thornquist MD et al.: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150–1155.
22. Permanetter B: Co-Enzym-Q-10. Internist Prax 1994; 34: 936–937.
23. Podmore ID, Griffiths HR, Herbert KE et al.: Vitamin C exhibits pro-oxidant properties. Nature 1998; 392: 559.
24. Rapola JM, Virtamo J, Ripatti S et al.: Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction. Lancet 1997; 349: 1715–1720.
25. Rau R: Vitamin E in der Rheumatherapie? Z Rheumatol 1998; 57: 203–206.
26. Rayman MP: The importance of selenium to human health. Lancet 2000; 356: 233–241.
27. Reiter S: Anwendung von Vitamin E bei rheumatischen Erkrankungen? Bundesgesundhbl 1998: 438-441.
28. Rothman KJ, Moore LL, Singer MR et al.: Teratogenicity of high vitamin A intake. N Engl J Med 1995; 333: 1369–1373.
29. Salvini S, Hennekens CH, Morris JS, Willett WC, Stampfer MJ: Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. Am J Cardiol 1995; 76: 1218–1221.
30. Stephens NG, Parsons A, Schofield PM et al.: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996; 347: 781–786.
31. Tröger U, Meyer FP: Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet. Br Med J 1998; 317:1069–1071.
«‹123»Seite
3 Artikel mit Literatur, Seite 1 von 3

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in